While the COVID-19 vaccines introduced many people to RNA-based medicines, RNA oligonucleotides have already been on the market for years to treat diseases like Duchenne Muscular Dystrophy and amyloidosis.
HCA says smaller share of spending going to labor
The chief executive of the country’s biggest hospital chain said Thursday that labor costs are now lower as a percent of revenue than they were